Amneal Pharmaceuticals Inc. – Indentures

NASDAQ: AMRX
Share price (5/21/26): $12.42
Market cap (5/21/26): $3.962 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Indentures Filter

from 8-K 236 pages Indenture Dated as of August 1, 2025 Among Amneal Pharmaceuticals LLC, as Issuer, the Guarantors Party Hereto and Wilmington Savings Fund Society, Fsb as Trustee and as Collateral Agent 6.875% Senior Secured Notes Due 2032

from 10-K 3 pages Description of Capital Stock

from S-3ASR 45 pages Amneal Pharmaceuticals, Inc. Indenture Dated as of [ , 20__] [ ] Trustee

from 10-K 2 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

from SC 13D/A 16 pages Securities Account Sole Control Agreement Date: June 10, 2019

from S-3ASR 51 pages Amneal Pharmaceuticals, Inc. Indenture Dated as of , 20 [ ] Trustee

from S-1 4 pages Second Supplemental Indenture

from S-1 4 pages First Supplemental Indenture

from S-1 111 pages Impax Laboratories, Inc. and Wilmington Trust, National Association, as Trustee Indenture Dated as of June 30, 2015 2.00% Convertible Senior Notes Due 2022

from 8-K 4 pages Second Supplemental Indenture

from S-1/A 4 pages First Supplemental Indenture

from S-1/A 111 pages Impax Laboratories, Inc. and Wilmington Trust, National Association, as Trustee Indenture Dated as of June 30, 2015 2.00% Convertible Senior Notes Due 2022